Yahoo
LSE - Delayed Quote GBp

Reckitt Benckiser Group plc (RKT.L)

5,114.00 +34.00 (+0.67%)
At close: 4:56:08 PM GMT+1
Chart Range Bar
Loading chart for RKT.L
  • Previous Close 5,080.00
  • Open 5,064.00
  • Bid 5,050.00 x --
  • Ask 5,556.00 x --
  • Day's Range 5,054.00 - 5,142.00
  • 52 Week Range 3,664.00 - 6,522.92
  • Volume 878,926
  • Avg. Volume 1,543,721
  • Market Cap (intraday) 32.458B
  • Beta (5Y Monthly) 0.25
  • PE Ratio (TTM) 11.54
  • EPS (TTM) 4.43
  • Earnings Date --
  • Forward Dividend & Yield 2.16 (4.26%)
  • Ex-Dividend Date Aug 6, 2026
  • 1y Target Est 6,239.05

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

www.reckitt.com

36,200

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

RKT.L
18.14%
FTSE 100 (^FTSE)
9.06%

1-Year Return

RKT.L
13.47%
FTSE 100 (^FTSE)
17.51%

3-Year Return

RKT.L
13.70%
FTSE 100 (^FTSE)
45.33%

5-Year Return

RKT.L
13.51%
FTSE 100 (^FTSE)
51.73%

Analyst Insights

View More

Analyst Price Targets

5,352.00
6,239.05 Average
5,114.00 Current
7,500.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 9/2/2026
  • Market Cap

    33.16B

  • Enterprise Value

    42.45B

  • Trailing P/E

    11.78

  • Forward P/E

    14.77

  • PEG Ratio (5yr expected)

    2.20

  • Price/Sales (ttm)

    2.49

  • Price/Book (mrq)

    5.85

  • Enterprise Value/Revenue

    3.11

  • Enterprise Value/EBITDA

    9.23

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.09%

  • Return on Assets (ttm)

    7.88%

  • Return on Equity (ttm)

    48.02%

  • Revenue (ttm)

    13.64B

  • Net Income Avi to Common (ttm)

    2.89B

  • Diluted EPS (ttm)

    4.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    878M

  • Total Debt/Equity (mrq)

    179.74%

  • Levered Free Cash Flow (ttm)

    3.09B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: